Profilo
James A. Vollins worked as Secretary & Chief Compliance Officer at Bio Products Laboratory Ltd. from 2014 to 2018.
Then, served as Secretary & Chief Compliance Officer at BioDelivery Sciences International, Inc. from 2018 to 2022.
Most recently, held the position of Secretary & Chief Compliance Officer at Eiger BioPharmaceuticals, Inc. from 2023 to 2024.
Education includes undergraduate studies at Wesleyan University and graduate studies at Case Western Reserve University School of Law.
Precedenti posizioni note di James Vollins
| Società | Posizione | Fine |
|---|---|---|
| EIGER BIOPHARMACEUTICALS | Responsabile della Conformità | 01/01/2024 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Responsabile della Conformità | 22/03/2022 |
Bio Products Laboratory Ltd.
Bio Products Laboratory Ltd. Pharmaceuticals: MajorHealth Technology Produces human blood plasma products to treat neurological & immunodeficiency and coagulation diseases | Responsabile della Conformità | 01/10/2018 |
Formazione di James Vollins
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
BioDelivery Sciences International, Inc.
BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain | Health Technology |
Wesleyan University
Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bio Products Laboratory Ltd.
Bio Products Laboratory Ltd. Pharmaceuticals: MajorHealth Technology Produces human blood plasma products to treat neurological & immunodeficiency and coagulation diseases | Health Technology |
Case Western Reserve University School of Law
Case Western Reserve University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eiger BioPharmaceuticals, Inc.
Eiger BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat and cure hepatitis delta virus and other serious diseases | Health Technology |
















